昊海生物科技(06826)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06826 昊海生物科技

交易中 10-22 10:26:42

15.330

-0.300

-1.92%

最高15.480	最低15.330	成交量5,000
今开15.450	昨收15.630	日振幅0.96%
总市值35.11亿	流通市值5.33亿	总股本2.29亿
成交额7.70万	换手率0.01%	流通股本3,478万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06826","market":"HK","secType":"STK","nameCN":"昊海生物科技","latestPrice":15.33,"timestamp":1792635857171,"preClose":15.63,"halted":0,"volume":5000,"delay":0,"changeRate":-0.0191938579654511,"floatShares":34780300,"shares":229000000,"eps":1.2695190270694392,"marketStatus":"交易中","change":-0.3,"latestTime":"10-22 10:26:42","open":15.45,"high":15.48,"low":15.33,"amount":77032,"amplitude":0.009597,"askPrice":15.33,"askSize":300,"bidPrice":15.3,"bidSize":1600,"shortable":0,"etf":0,"ttmEps":0.7781810746567281,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1792641600000},"marketStatusCode":2,"adr":0,"listingDate":1430323200000,"exchange":"SEHK","adjPreClose":15.63,"dividendRate":0.064709,"openAndCloseTimeList":[[1792632600000,1792641600000],[1792645200000,1792656000000]],"volumeRatio":0.407962,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688366","market":"SH","secType":"STK","nameCN":"昊海生科","latestPrice":29.54,"timestamp":1792635968000,"preClose":29.56,"halted":0,"volume":157400,"delay":0,"premium":"-55.85"}},"requestUrl":"/m/hq/s/06826","defaultTab":"news","newsList":[{"id":"2674878266","title":"昊海生物科技(06826.HK)拟10月23日举行董事会会议批准季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2674878266","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674878266?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:47","pubTimestamp":1791794822,"startTime":"0","endTime":"0","summary":"格隆汇10月12日丨昊海生物科技(06826.HK)发布公告，谨定于2026年10月23日(星期五)举行董事会会议，藉以(其中包括)审议及通过公司及其附属公司截至2026年9月30日止九个月的第三季度业绩及其发布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261012/32393701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["06826","BK1161","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183011294","title":"昊海生物科技（06826）拟于10月23日召开董事会审议第三季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1183011294","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183011294?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:42","pubTimestamp":1791794545,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司（06826）10月12日公告，董事会会议拟定于2026年10月23日（星期五）召开。\n会议议程包括审议及通过公司及其附属公司截至2026年9月30日止九个月的2026年第三季度业绩及其发布事宜。\n公告显示，截至公告披露日，公司董事会由4名执行董事、3名非执行董事及4名独立非执行董事组成。公司现任董事会主席为吴剑英。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131900798","title":"昊海生物科技2026年9月股份变动月报：股本维持稳定，回购股份尚未注销","url":"https://stock-news.laohu8.com/highlight/detail?id=1131900798","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131900798?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:53","pubTimestamp":1790758408,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年9月30日发布了截至当月的证券变动月报。公告显示，公司注册股本为人民币228,832,195元，包含H股和A股两类普通股，报告期内未发生新的股份发行或注销，整体股本结构保持稳定。公告中同时披露，公司自2026年5月29日起已回购合计926,300股H股，但截至9月末尚未完成注销。公司强调将继续确保股本结构合规，并保持对股东权益的关注。未来若有进一步股份变动事项，将及时披露相关信息。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669124624","title":"股市必读：XD昊海生物科技新发布《H股公告：翌日披露报表》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669124624","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669124624?lang=zh_cn&edition=full","pubTime":"2026-09-23 03:26","pubTimestamp":1790105181,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘，XD昊海生物科技报收于30.1元，上涨0.8%，换手率0.28%，成交量5468.0手，成交额1645.08万元。公司公告汇总H股公告：翌日披露报表上海昊海生物科技股份有限公司于2026年9月21日提交翌日披露报表，报告显示公司于当日购回27,500股H股，每股购回价介乎15.8至15.96港元，总代价为438,274港元。该等股份拟注销，不持有作库存股份。截至2026年9月21日，公司累计已根据授权购回926,300股H股，占授权时已发行股份的2.6633%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300004710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130884705","title":"昊海生物科技9月21日回购2.75万股H股，斥资约43.83万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130884705","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130884705?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:36","pubTimestamp":1789983417,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年9月21日发布公告，披露当日通过香港联合交易所场内回购普通股H股27,500股，占该公司回购前H股已发行股本的约0.0122%。回购价介乎每股15.80港元至15.96港元，总金额438,274港元，折合约43.83万港元。根据公告，完成此次回购前后，昊海生物科技H股股本数为34,780,340股未发生变化，A股股本数为190,203,760股，合计普通股224,984,100股。公告显示，公司已严格遵守相关上市规则及适用法律法规开展上述回购。该等回购股份尚未注销。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技9月21日回购2.75万股H股，斥资约43.83万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669151754","title":"昊海生物科技(06826)9月21日斥资43.83万港元回购2.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669151754","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669151754?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:22","pubTimestamp":1789982572,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，该公司于2026年9月21日斥资43.83万港元回购2.75万股股份，每股回购价格为15.8-15.96港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669509139","title":"医美概念股多股上扬 三生制药（01530）涨5.71%、四环医药（00460）涨4.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669509139","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669509139?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:09","pubTimestamp":1789956581,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医美概念股多股上扬，截至发稿，山东新华制药股份 涨10.81%，三生制药涨5.71%，四环医药涨4.17%，昊海生物科技涨3.82%，复星医药涨3.12%，现代牙科涨3.10%，时代天使涨2.25%。消息面上，国金证券表示，医美板块下游连锁景气回暖，上游平台化逻辑有望兑现，建议关注上游头部连锁化机构、需求扩容下具备强渠道能力的上游平台化标的。看好布局差异化赛道的上游医美产品厂商及满足医美新场景需求的下游医美机构。","market":"sh","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992051","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1587","BK1191","BK1593","BK1515","02196","06826","00719","BK1600","03600","01530","HK0000165453.HKD","BK1100","BK1583","06699","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174702185","title":"昊海生物科技：9月18日回购6.7万股H股，耗资约101.84万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174702185","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174702185?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:25","pubTimestamp":1789723556,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年9月18日发布公告，披露在香港联合交易所进行股份回购的最新情况。该公司于当日以每股15.20港元的价格回购H股67,000股，占公司现有已发行股份总数约0.0298%，合计耗资约101.84万港元。公告显示，截至此次回购前，昊海生物科技总计已发行224,984,100股普通股。本次回购完成后，上述已发行股本及库存股份数量暂未发生变化，被回购的股份尚待注销。本次公告由公司董事兼联席公司秘书田敏签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技：9月18日回购6.7万股H股，耗资约101.84万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668794432","title":"昊海生物科技(06826.HK)9月18日斥资101.84万港元回购6.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668794432","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668794432?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:22","pubTimestamp":1789723376,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115578136","title":"昊海生物科技(06826)因回购股份调整2026年中期分红总额至5,608.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115578136","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115578136?lang=zh_cn&edition=full","pubTime":"2026-09-13 18:15","pubTimestamp":1789294532,"startTime":"0","endTime":"0","summary":"2026年9月14日，上海昊海生物科技股份有限公司公告称，公司对2026年半年度利润分配方案的现金分红总额进行调整。分红比例保持不变，仍向全体股东每10股派发现金红利人民币2.50元（含税）。根据公告，自2026年8月22日初次披露分配方案至2026年9月11日期间，公司实施股份回购，新增不参与本次利润分配的已回购但尚未注销H股股份418,500股。公司此前披露，分红总额占2026年半年度合并报表归属于上市公司股东净利润的49.89%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137111362","title":"昊海生物科技（06826）拟实施差异化权益分派：每10股派2.50元，3,848,095股回购股份不参与分配","url":"https://stock-news.laohu8.com/highlight/detail?id=1137111362","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137111362?lang=zh_cn&edition=full","pubTime":"2026-09-13 18:11","pubTimestamp":1789294283,"startTime":"0","endTime":"0","summary":"2026年9月13日，昊海生物科技发布海外监管公告，并披露上海市锦天城律师事务所就公司差异化权益分派事项出具的法律意见书。第一期开启于2023年，至2024年8月15日累计回购2,015,674股，耗资192,839,755.99元；第二期开启于2024年，至2025年8月14日累计回购1,832,421股，耗资103,905,394.55元。– 截至本法律意见书出具日，公司通过集中竞价方式累计回购A股3,848,095股，占公司总股本228,832,195股的1.68%。公司提醒投资者关注差异化权益分派实施的具体安排及后续进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194738513","title":"昊海生物科技回购24,300股股份，总金额约39.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194738513","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194738513?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:06","pubTimestamp":1789117582,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年9月11日公布翌日披露报表，披露当日在香港联交所场内回购了24,300股H股，占该公司截至回购前已发行股本约0.0108%。本次回购每股价格介乎16.31港元至16.68港元，合计耗资约39.99万港元。公告显示，此次回购股份尚未进行注销。根据公告，昊海生物科技的回购授权由股东大会于2026年5月29日批准，授予可回购股份总数为3,478,034股。公司强调本次回购及其相关手续均符合香港联交所上市规则及适用法律法规的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技回购24,300股股份，总金额约39.99万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666404595","title":"昊海生物科技：9月11日斥资40万港元回购24300股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666404595","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666404595?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:06","pubTimestamp":1789117560,"startTime":"0","endTime":"0","summary":"南财智讯9月11日电，昊海生物科技（06826.HK）发布翌日披露报表，公司于2026年9月11日在香港联合交易所进行股份回购，回购股份数量为24300股，每股最高回购价16.68港元，每股最低回购价16.31港元，付出的总代价为399865港元。回购股份拟注销，未持作库存股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609113872133540.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609113872133540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666127155","title":"【券商聚焦】中信建投：医疗器械板块业绩有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2666127155","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666127155?lang=zh_cn&edition=full","pubTime":"2026-09-11 09:18","pubTimestamp":1789089493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。该机构认为，随着集采影响逐步出清叠加创新驱动和海外业务加速的双重助力，医疗器械板块业绩有望逐步改善。尽管季度业绩增速可能有所波动，Q3能否相比Q2加速尚不确定，但大趋势来看，26和27年年度业绩持续改善的确定性较强。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","601066","BK1585","159883","GDOC","BK1247","BK1571","PTH","AGNG","01066","LU0173614495.USD","BK1593","LNGR","HK0000165453.HKD","IEIH","BK1161","BK1584","BK1515","HART","00853","MEDX","BK1589","02235","BK1591","09996","BK1189","BK1222","BK1615","BK1600","BK1587","BK1610","MDEV","02190","BK1501","BK1583","06826","LGHT","01302","KCE","BK1617","RSPH","00241","BK1100","BK0276","LU0287142896.SGD","BK1142","02252","BK1502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109772495","title":"昊海生物科技：9月10日回购4.8万股H股，涉资约79.57万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1109772495","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109772495?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:46","pubTimestamp":1789033574,"startTime":"0","endTime":"0","summary":"2026年9月10日，昊海生物科技公告，基于2026年5月29日获得的购回授权，公司于当日在香港联交所场内回购H股4.8万股，占本次回购日前已发行股份合计224,984,100股的约0.0213%。回购价格区间介乎每股港币16.47元至16.76元，合计支付约79.57万港元。根据公告，公司于该日回购的股份尚未注销。公司表示，本次回购已获得董事会正式授权，并遵守香港联交所证券上市规则及有关适用法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技：9月10日回购4.8万股H股，涉资约79.57万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666610625","title":"昊海生物科技(06826)9月10日耗资约79.57万港元回购4.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666610625","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666610625?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:41","pubTimestamp":1789033302,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)公布，2026年9月10日耗资约79.57万港元回购4.8万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666060561","title":"昊海生物科技(06826.HK)9月10日耗资约79.57万港元回购4.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666060561","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666060561?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:41","pubTimestamp":1789033302,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195657736","title":"昊海生物科技更新2026年8月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1195657736","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195657736?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:46","pubTimestamp":1788947209,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年9月9日发布2026年8月股份变动月报。截至2026年8月31日，公司股本结构总体保持稳定，未发生新增发行或注册股本变动。此前，公司已于2026年5月29日回购607,000股H股，相关股份尚未完成注销。公告同时指出，公司已遵守相关上市规则和相关法律规定。本次公告由公司联席公司秘书田敏于2026年9月9日签署并提交。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156465753","title":"昊海生物科技9月9日回购1万股，耗资约16.68万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1156465753","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156465753?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:32","pubTimestamp":1788946357,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年9月9日发布翌日披露报表，公告回购股票的最新情况。本次回购股份涉及H股，共计1万股，占公司已发行H股股本约0.0044%，回购价格介乎每股16.64港元至16.80港元，合计支付约16.68万港元。上述回购股份尚未注销。公司此前于2026年5月29日通过回购授权，拟回购股数为3,478,034股。截至此次回购完成后，公司已累计回购759,500股，约占回购授权决议通过当日公司已发行股份总数的2.1837%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技9月9日回购1万股，耗资约16.68万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148421415","title":"昊海生物科技：9月8日回购3.15万股，耗资约52.93万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1148421415","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148421415?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:26","pubTimestamp":1788945983,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年9月9日发布公告，披露近期在香港联交所进行股份回购的情况。公司于2026年9月8日于香港联交所场内回购H股3.15万股，占公司现有已发行股本约0.014%。每股回购价格区间介乎每股16.76港元至16.84港元，共斥资约52.93万港元。公告显示，公司回购授权已于2026年5月29日获股东大会通过，获准购买的股份数量为3,478,034股。截至最新，公司共在香港联交所及其他市场合计回购了749,500股，占授权总额约2.155%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技：9月8日回购3.15万股，耗资约52.93万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3healthcare.com/","stockEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.0194},{"period":"3month","weight":-0.0255},{"period":"6month","weight":-0.2252},{"period":"1year","weight":-0.3821},{"period":"ytd","weight":-0.3224}],"compareEarnings":[{"period":"1week","weight":-0.0272},{"period":"1month","weight":-0.0555},{"period":"3month","weight":-0.0618},{"period":"6month","weight":-0.0895},{"period":"1year","weight":-0.0913},{"period":"ytd","weight":-0.0772}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海昊海生物科技股份有限公司是一家主要从事生产及销售生物制品、医用透明质酸及人工晶状体、研发生物工程及药品及提供相关服务的中国公司。眼科业务已覆盖白内障治疗、近视防控与屈光矫正及眼表用药、提供人工晶状体及角膜塑形镜等产品的视光材料。医疗美容与创面护理产品覆盖玻尿酸真皮填充剂、皮肤和黏膜浅层组织补充用透明质酸凝胶等。骨科产品包含骨科关节腔黏弹补充剂等。防黏连及止血产品包括医用几丁糖（防黏连用）、医用透明质酸钠凝胶和胶原蛋白海绵。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.002081},{"month":2,"riseRate":0.363636,"avgChangeRate":0.018834},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.014563},{"month":4,"riseRate":0.818182,"avgChangeRate":0.062966},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.022119},{"month":6,"riseRate":0.25,"avgChangeRate":-0.018495},{"month":7,"riseRate":0.583333,"avgChangeRate":0.058199},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.02166},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.014306},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.030487},{"month":11,"riseRate":0.545455,"avgChangeRate":-0.009611},{"month":12,"riseRate":0.545455,"avgChangeRate":0.02266}],"exchange":"SEHK","name":"昊海生物科技","nameEN":"HAOHAI BIOTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昊海生物科技(06826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昊海生物科技(06826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昊海生物科技,06826,昊海生物科技股票,昊海生物科技股票老虎,昊海生物科技股票老虎国际,昊海生物科技行情,昊海生物科技股票行情,昊海生物科技股价,昊海生物科技股市,昊海生物科技股票价格,昊海生物科技股票交易,昊海生物科技股票购买,昊海生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昊海生物科技(06826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昊海生物科技(06826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}